In heart diseases like cardiac hypertrophy, heart failure, and myocardial ischemia different perturbations in expression of glucose transporters are observed, especially in GLUT1 and GLUT4, due to changes in heart glucose metabolism. Here, SLC2A1 is linked to myocardial ischemia.